Oncotarget

Vol 9, No 93

November 27, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 93 of Oncotarget features Figure 2, "Comparison of overall survival (OS) and leukemia-free survival (LFS) between CloB2A1 and CloB2A2 sub-groups," by Le Bourgeois, et al.

Table of Contents

Editorial

CLAG-M with dose-escalated mitoxantrone for adults with acute myeloid leukemia

CLAG-M with dose-escalated mitoxantrone for adults with acute myeloid leukemia

https://doi.org/10.18632/oncotarget.26383

Anna B. Halpern,  and Roland B. Walter
36543-36544
PDF  |  Order a Reprint

Cancer immunotherapy: Moving beyond checkpoint inhibition

Cancer immunotherapy: Moving beyond checkpoint inhibition

https://doi.org/10.18632/oncotarget.26384

Marianne Boes
36545-36546
PDF  |  Order a Reprint

Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancer

Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancer

https://doi.org/10.18632/oncotarget.26389

Francois Ghiringhelli,  and Caroline Truntzer
36547-36548
PDF  |  Order a Reprint

Using genomics to better define high-risk MGUS/SMM patients

Using genomics to better define high-risk MGUS/SMM patients

https://doi.org/10.18632/oncotarget.26390

Ankit K. Dutta, Duncan R. Hewett, J. Lynn Fink,  and Andrew C.W. Zannettino
36549-36550
PDF  |  Order a Reprint

Research Papers

IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI

IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI

https://doi.org/10.18632/oncotarget.25663

Hai-Lun Li, Zhuan Yan, Zun-Ping Ke, Xiao-Feng Tian, Li-Li Zhong, Yong-Tao Lin, Yong Xu,  and Dong-Hui Zheng
36551-36560
Abstract  |  PDF  |  HTML  |  Order a Reprint

Significance of intranuclear angiotensin-II type 2 receptor in oral squamous cell carcinoma

Significance of intranuclear angiotensin-II type 2 receptor in oral squamous cell carcinoma

https://doi.org/10.18632/oncotarget.26337

Sayako Matsushima-Otsuka, Rina Fujiwara-Tani, Takamitsu Sasaki, Hitoshi Ohmori, Chie Nakashima, Shingo Kishi, Yukiko Nishiguchi, Kiyomu Fujii, Yi Luo,  and Hiroki Kuniyasu
36561-36574
Abstract  |  PDF  |  HTML  |  Order a Reprint

Preoperative diffusion-weighted magnetic resonance imaging and intraoperative frozen sections for predicting the tumor grade in endometrioid endometrial cancer

Preoperative diffusion-weighted magnetic resonance imaging and intraoperative frozen sections for predicting the tumor grade in endometrioid endometrial cancer

https://doi.org/10.18632/oncotarget.26366

Tomohito Tanaka, Yoshito Terai, Satoe Fujiwara, Yoshimichi Tanaka, Hiroshi Sasaki, Satoshi Tsunetoh, Kazuhiro Yamamoto, Takashi Yamada, Yoshifumi Narumi,  and Masahide Ohmichi
36575-36584
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expression

Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expression

https://doi.org/10.18632/oncotarget.26379

Daiana L. Vitale, Fiorella M. Spinelli, Daiana Del Dago, Antonella Icardi, Gianina Demarchi, Ilaria Caon, Mariana García, Marcela F. Bolontrade, Alberto Passi, Carolina Cristina,  and Laura Alaniz
36585-36602
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC

Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC

https://doi.org/10.18632/oncotarget.26391

Amandine Le Bourgeois, Myriam Labopin, Mathieu Leclerc, Régis Peffault de Latour, Jean-Henri Bourhis, Patrice Ceballos, Corentin Orvain, Hélène Labussière Wallet, Karin Bilger, Didier Blaise, Marie-Thérese Rubio, Thierry Guillaume, Mohamad Mohty, Patrice Chevallier,  and on behalf of Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
36603-36612
Abstract  |  PDF  |  HTML  |  Order a Reprint

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia

https://doi.org/10.18632/oncotarget.26400

Nikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, Goutham Raval, Prasanna Bhanshe, Swapnali Joshi, Shruti Chaudhary, Y. Badrinath, Sitaram Ghoghale, Shraddha Kadechkar, Syed Hasan Khizer, Sadhana Kannan, Dhanalaxmi Shetty, Anant Gokarn, Sachin Punatkar, Hasmukh Jain, Bhausaheb Bagal, Hari Menon, Manju Sengar, Navin Khattry, Prashant Tembhare, Papagudi Subramanian,  and Sumeet Gujral
36613-36624
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Meta-Analysis

Meta-analysis of the likelihood of FOXC1 expression in early- and late-stage tumors

Meta-analysis of the likelihood of FOXC1 expression in early- and late-stage tumors

https://doi.org/10.18632/oncotarget.26358

Tsutomu Kume,  and Tarek Shackour
36625-36630
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Reviews

Tumour treating fields in a combinational therapeutic approach

Tumour treating fields in a combinational therapeutic approach

https://doi.org/10.18632/oncotarget.26344

Joshua Branter, Surajit Basu,  and Stuart Smith
36631-36644
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

https://doi.org/10.18632/oncotarget.26415

Kimberley Hanson, Stephen D. Robinson, Karamallah Al-Yousuf, Adam E. Hendry, Darren W. Sexton, Victoria Sherwood,  and Grant N. Wheeler
36645-36645
Correction  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC